Listing 1 - 2 of 2 |
Sort by
|
Choose an application
This book collects multidisciplinary research articles focused on Clostridioides difficile infection. The contributions collected here shed some light on grey areas of our knowledge of Clostridioides difficile, including regional Clostridioides difficile phenotypic and genotypic patterns, the Clostridioides difficile infection clinical course and the mortality rate in different settings and patient case-mix, the levels of Clostridioides difficile toxins in patients' sera, and novel, promising therapeutic approaches. This collection serves as a valuable reservoir of knowledge for scientists and researchers in the field of infectious diseases.
Medicine --- Epidemiology & medical statistics --- Clostridioides difficile infection --- co-morbidities --- mortality --- malignancy --- outcome --- risk factors --- C. difficile infection --- molecular analysis --- toxin production --- antibiotic resistance --- microbiome --- C. difficile --- hamsters --- bovine immunoglobulins --- 16S rRNA --- next generation sequencing --- Clostridioides difficile --- Charlson comorbidity index --- Child-Pugh score --- Clostridioides difficile associated disease --- CDI --- nonalcoholic fatty liver disease --- NAFLD --- NASH --- recurrent disease --- antibacterial --- Clostridioides (Clostridium) difficile --- peptidomimetic --- triazole --- baicalin --- gut dysbiosis --- mouse model --- spores --- anti-spore --- spore germination --- nanomaterial --- teicoplanin --- spore --- antibiotics --- multi-step algorithm --- multiplex "real-time" PCR --- PCR capillary-based electrophoresis ribotyping --- Clostridium difficile --- TcdA --- TcdB --- toxin --- toxemia --- plasma --- method --- quantification --- CDI severity --- Clostridioides difficile infection --- co-morbidities --- mortality --- malignancy --- outcome --- risk factors --- C. difficile infection --- molecular analysis --- toxin production --- antibiotic resistance --- microbiome --- C. difficile --- hamsters --- bovine immunoglobulins --- 16S rRNA --- next generation sequencing --- Clostridioides difficile --- Charlson comorbidity index --- Child-Pugh score --- Clostridioides difficile associated disease --- CDI --- nonalcoholic fatty liver disease --- NAFLD --- NASH --- recurrent disease --- antibacterial --- Clostridioides (Clostridium) difficile --- peptidomimetic --- triazole --- baicalin --- gut dysbiosis --- mouse model --- spores --- anti-spore --- spore germination --- nanomaterial --- teicoplanin --- spore --- antibiotics --- multi-step algorithm --- multiplex "real-time" PCR --- PCR capillary-based electrophoresis ribotyping --- Clostridium difficile --- TcdA --- TcdB --- toxin --- toxemia --- plasma --- method --- quantification --- CDI severity
Choose an application
Beyond being the most important natural compound source, actinomycetes are the origin of up to two-thirds of all clinically used antibiotics. Currently, new antimicrobials are urgently needed, as infections caused by antibiotic-resistant pathogens are on the rise. In the identification of new antibiotics, many scientists are currently investigating biosynthetic aspects of antibiotic production in actinomycetes. Since the emergence of next-generation sequencing technologies, the field of antibiotics research has experienced a remarkable revival. These bacteria have the potential to produce more antibiotics than previously thought possible. Some antibiotics are produced in standard media, while others require the presence of a specific signaling molecule in the medium. Others, however, are only produced when the native regulation of the biosynthesis gene cluster is overruled. This book covers topics in the field of antibiotic-producing actinomycetes. The following tops are addressed: - Approaches to access novel antibiotic producers for novel natural compounds - Omics and genome mining approaches for the discovery of novel natural compounds - Analyses and genetic engineering of antibiotic biosynthesis - Regulation of the secondary metabolism in actinomycetes
Research & information: general --- Biology, life sciences --- Streptomyces --- biogeography --- comparative genomics --- diversification --- secondary metabolite biosynthetic gene clusters --- SMGC --- natural products --- streptomyces --- rishirilide --- biosynthesis --- polyketides --- polynucleotide phosphorylase --- ribonuclease --- regulation --- promoter --- RNA decay --- polyadenylation --- (p)ppGpp --- antibiotic --- antibiotics --- geomicrobiology --- Illumina sequencing --- microbiome diversity --- Actinobacteria --- Cave microbiology --- secondary metabolite --- rare Actinobacteria --- Amycolatopsis --- unculturability --- siderophore --- glycopeptide antibiotics --- dbv cluster --- regulatory genes --- StrR --- LAL --- LuxR solo --- dalbavancin --- A40926 --- Streptomyces lividans --- secretion pathways --- secretory proteins --- signal peptides --- actinomycetes --- teicoplanin --- van resistance genes --- Streptomyces tsukubaensis --- tacrolimus --- FK506 --- omics --- screening --- secondary metabolism --- differentiation --- elicitors --- morphology --- liquid cultures --- metagenomics --- rare actinomycetes --- dereplication --- metabolomics --- genome mining --- secondary metabolites --- novel compounds --- physicochemical screening --- physical and chemical properties --- structural diversity --- biological activity --- Actinoallomurus --- antibiotics polyethers --- lysolipin --- minimal PKS II --- cyclases --- benz[a]naphthacene quinone --- tridecaketide --- aromatic polyketide --- pentacyclic angular polyphenol --- extended polyketide chain --- actinobacteria --- β-lactamase --- resistance --- β-lactamase inhibitor --- polyketide synthases --- acyltransferases --- engineering --- new bioactive compounds --- symbiosis --- drug discovery --- chemical ecology --- culture-based approaches --- strain --- specialized metabolites --- biosynthetic gene cluster --- Streptomyces --- biogeography --- comparative genomics --- diversification --- secondary metabolite biosynthetic gene clusters --- SMGC --- natural products --- streptomyces --- rishirilide --- biosynthesis --- polyketides --- polynucleotide phosphorylase --- ribonuclease --- regulation --- promoter --- RNA decay --- polyadenylation --- (p)ppGpp --- antibiotic --- antibiotics --- geomicrobiology --- Illumina sequencing --- microbiome diversity --- Actinobacteria --- Cave microbiology --- secondary metabolite --- rare Actinobacteria --- Amycolatopsis --- unculturability --- siderophore --- glycopeptide antibiotics --- dbv cluster --- regulatory genes --- StrR --- LAL --- LuxR solo --- dalbavancin --- A40926 --- Streptomyces lividans --- secretion pathways --- secretory proteins --- signal peptides --- actinomycetes --- teicoplanin --- van resistance genes --- Streptomyces tsukubaensis --- tacrolimus --- FK506 --- omics --- screening --- secondary metabolism --- differentiation --- elicitors --- morphology --- liquid cultures --- metagenomics --- rare actinomycetes --- dereplication --- metabolomics --- genome mining --- secondary metabolites --- novel compounds --- physicochemical screening --- physical and chemical properties --- structural diversity --- biological activity --- Actinoallomurus --- antibiotics polyethers --- lysolipin --- minimal PKS II --- cyclases --- benz[a]naphthacene quinone --- tridecaketide --- aromatic polyketide --- pentacyclic angular polyphenol --- extended polyketide chain --- actinobacteria --- β-lactamase --- resistance --- β-lactamase inhibitor --- polyketide synthases --- acyltransferases --- engineering --- new bioactive compounds --- symbiosis --- drug discovery --- chemical ecology --- culture-based approaches --- strain --- specialized metabolites --- biosynthetic gene cluster
Listing 1 - 2 of 2 |
Sort by
|